Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Rhea-AI Summary

Moderna (NASDAQ:MRNA) will report third quarter 2025 financial results on Thursday, November 6, 2025 with a live conference call and webcast at 8:00 a.m. ET.

The live webcast will be available under "Events and Presentations" in the Investors section of Moderna's website at https://investors.modernatx.com. An archived webcast will be posted about two hours after the call and will remain available for one year.

News Market Reaction

-2.09%

1 alert

-2.09% News Effect

On the day this news was published, MRNA declined 2.09%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CAMBRIDGE, MA, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to report its third quarter 2025 financial results, and provide a corporate update.

A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.

• Webcast: https://investors.modernatx.com

The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Media Contacts

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Moderna (MRNA) report Q3 2025 results?

Moderna will report Q3 2025 results on Thursday, November 6, 2025 with a call at 8:00 a.m. ET.

How can I listen to Moderna's (MRNA) Q3 2025 earnings call?

Listen via the live webcast under "Events and Presentations" on Moderna's investor website: https://investors.modernatx.com.

Will Moderna (MRNA) provide an archived webcast of the Q3 2025 call?

Yes. The archived webcast will be posted about two hours after the call and will be available for one year.

What time is Moderna's (MRNA) Q3 2025 conference call?

The conference call is scheduled for 8:00 a.m. ET on November 6, 2025.

Where on Moderna's site is the webcast for the Q3 2025 results?

The webcast is under the Investors > Events and Presentations section on Moderna's website.

Will the Q3 2025 Moderna (MRNA) archived webcast remain available long-term?

The archived webcast will be available for one year after posting.